ANI Pharma Inc License Agreements
10 Contracts & Agreements
- THIRD AMENDMENT TO DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on November 8, 2012)
- FIRST AMENDMENT TO DEVELOPMENT AND LICENSE AGREEMENT (First Amendment) between TEVA PHARMACEUTICALS USA, INC. 1090 Horsham Road, North Wales, PA 19454 (Teva) and BIOSANTE... (Filed With SEC on November 8, 2012)
- DEVELOPMENT AND LICENSE AGREEMENT between TEVA PHARMACEUTICALS USA, INC. 1090 Horsham Road, North Wales, PA 19454 (Teva) and BIOSANTE PHARMACEUTICALS, INC. 111 Barclay Boulevard,... (Filed With SEC on November 8, 2012)
- Amendment No. 6 to the License Agreement dated 13th of June 2000 by and between Antares Pharma IPL AG, Zug, Switzerland as Licensor (formerly known as Permatec Technologies AG)... (Filed With SEC on March 16, 2011)
- Amendment No. 5 to the License Agreement dated 13thof June 2000 (the Agreement) by and between Antares Pharma IPL AG Zug, Switzerland as Licensor (formerly known as Permatec... (Filed With SEC on March 16, 2011)
- Amendment No. 4 to the License Agreement dated 13thof June 2000 (the Agreement) by and between Antares Pharma IPL AG, Zug, Switzerland as Licensor (formerly known as Permatec... (Filed With SEC on March 16, 2011)
- AMENDMENT NO. 3 to the License Agreement dated 13thof June, 2000 (the Agreement) by and between ANTARES Pharma IPL AG, Zug, Baarerstrasse 95, 6301 Zug, Switzerland as Licensor... (Filed With SEC on March 16, 2011)
- Amendment No. 1 to the License Agreement dated 13thof June 2000 (the Agreement) by and between Antares Pharma IPL AG, Zug, Switzerland as Licensor (formerly known as Permatec... (Filed With SEC on March 16, 2011)
- Amendment No. 6 to the License Agreement, dated October 20, 2006 between Antares Pharma IPL AG and BioSante Pharmaceuticals, Inc (Filed With SEC on March 27, 2007)
- Fourth Amendment to Exclusive License Agreement Agreement Control No. 1997-04-0671 for Selected Applications of Coated Nanocrystalline Particles between The Regents of the... (Filed With SEC on November 14, 2006)
